Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -27,232 | -69,995 | -12,400 | -26,488 |
| Accounts receivable | -1,499 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,055 | N/A | -686 | N/A |
| Other Working Capital | 251 | -4,533 | -1,476 | 732 |
| Other Operating Activity | 8,367 | 2,926 | 1,245 | 2,068 |
| Operating Cash Flow | $-21,168 | $-71,602 | $-13,317 | $-23,688 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -122,988 | N/A | -15,731 | N/A |
| PPE Investments | N/A | -24 | -19 | 0 |
| Sale Of Investment | 21,689 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -118,834 | 0 | 0 |
| Investing Cash Flow | $-101,299 | $-118,858 | $-15,750 | $0 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 269,113 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 159,142 | 8,423 | 60,476 |
| Financing Cash Flow | $269,113 | $159,142 | $8,423 | $60,476 |
| Beginning Cash Position | 21,766 | 53,084 | 53,084 | 16,296 |
| End Cash Position | 168,412 | 21,766 | 32,440 | 53,084 |
| Net Cash Flow | $146,646 | $-31,318 | $-20,644 | $36,788 |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,168 | -71,602 | -13,317 | -23,688 |
| Capital Expenditure | N/A | N/A | -19 | N/A |
| Free Cash Flow | -21,168 | -71,602 | -13,336 | -23,688 |